level
PrivateLast Round
Series A
Nov 16, 2022
Est. Valuation
$20.34M
Total Funding Raised
$2.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
level operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Series A round in November 2022.
level (formerly NeuralMed) is a healthtech company that provides an AI-based intelligence platform to organize clinical and financial data for hospitals, clinics, and health insurance providers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Revenue Cycle, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
level Comparables
Compare level with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MV Sistemas | 66% | |
| Vela LatAm | 64% | |
| Laura | 62% |
For institutional investors. Book with your work email.
level Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 16, 2022 | ||||
| Seed | Aug 17, 2021 | ||||
| Pre Seed | Mar 24, 2021 | ||||
| Grant | Jun 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
level Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexia Ventures | Seed, Pre Seed |
| Norte Ventures | Seed, Pre Seed |
| MG Tech | Pre Seed |
| Good Karma Partners | Series A |
| Inter-American Development Bank | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 42% MoM.
- Apr 24, 2026
Monthly visitors increased 52% MoM.
For institutional investors. Book with your work email.
level Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about level's valuation, stock price, and market status.
Is level a public or private company?
level is a private company.
What is the current stock price of level?
level is a private company, so its shares have no public market price. Caplight tracks level's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is level worth (valuation)?
level's valuation is estimated at $20.3M based on funding round data.
Can I buy level stock?
level shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was level's last funding round?
level's most recent funding round was Series A on November 16, 2022.
Who are the main investors in level?
Key investors in level include Alexia Ventures, Norte Ventures, MG Tech, Good Karma Partners, Inter-American Development Bank.
Will level IPO soon?
No public IPO plans have been announced for level.
How can I track level secondary market activity?
Caplight tracks bids, offers, and trades in level's shares on secondary markets.